Phase 4 Parkinson's Disease Trial, Recruiting NCT06234995 Sponsor: Emory University Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 4 Parkinson's Disease Trial, Recruiting

NCT06234995
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's disease (Study Aim 1 – brain signal recording study):

  • People who have been diagnosed with Parkinson's disease that developed on its own (not caused by another condition)
  • People whose Parkinson's disease is rated at a moderate to moderately-severe level of severity (stages 2–4 on a standard scale), measured when not taking Parkinson's medication

For people with Parkinson's disease (Study Aim 2 – brain surgery study):

  • People who have been diagnosed with Parkinson's disease that developed on its own
  • People for whom their doctor has determined that a type of brain stimulation surgery (called Deep Brain Stimulation, or DBS) is medically appropriate
  • People whose pre-surgery brain scan (MRI) came back normal
  • People who are able to remain awake during a type of brain surgery that uses fine needle recordings to guide placement

For people with Parkinson's disease (Study Aim 3 – existing DBS device study):

  • People who have been diagnosed with Parkinson's disease that developed on its own
  • People who already have a working DBS brain stimulation device implanted

For healthy volunteers (no Parkinson's diagnosis):

  • People aged between 45 and 75 years old

Who may not be able to join:

For people with Parkinson's disease (Study Aim 1):

  • People whose Parkinson's causes severe shaking or severe uncontrolled movements that would interfere with brain signal recordings
  • People who are unable to temporarily stop taking their Parkinson's medications for the research recordings
  • People who have dementia
  • People who do not speak English

For people with Parkinson's disease (Study Aim 2):

  • People who have a blood clotting disorder
  • People who have high blood pressure that is not well controlled
  • People who have heart disease
  • People who have other health conditions that the medical team considers would increase the risk of complications from surgery

For people with Parkinson's disease (Study Aim 3):

  • People whose Parkinson's causes severe shaking or severe uncontrolled movements that would interfere with brain signal recordings
  • People who are unable to temporarily stop taking their Parkinson's medications for the research recordings
  • People who are unable to tolerate having their DBS device temporarily turned off or having its settings changed for research purposes
  • People who have other health conditions that the medical team considers would increase the risk of surgical complications

For healthy volunteers:

  • People who have a history of a neurological or psychiatric condition, or who have been treated with medications that affect mood or mental health
  • People who do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Svjetlana Miocinovic, MD, PhD, Emory University

Phone: 404-727-1509

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
9 August 2021
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Response Time During Go/No-Go (GNG) Task for Participants in Aim 1; Percent of Errors During Go/No-Go (GNG) Task for Participants in Aim 1; Stopping Time During Modified Stop Signal (MSS) Task for Participants in Aim 1; Response Time During Go/No-Go (GNG) Task for Participants in Aim 3; Percent of Errors During Go/No-Go (GNG) Task for Participants in Aim 3; Stopping Time During Modified Stop Signal (MSS) Task for Participants in Aim 3

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov